Glycemic Holter Study (Continuous Glucose Monitoring) -
NCT01193296
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Vildagliptin
DRUG:
Sitagliptin
Sponsor
Novartis